Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 32.67%4.05B | 33.10%6.7B | 16.64%3.05B | 43.85%5.04B | 43.03%2.62B | -4.15%3.5B | 34.64%1.83B | 27.75%3.65B | 46.56%1.36B | -0.55%2.86B |
| Operating income | 32.67%4.05B | 33.10%6.7B | 16.64%3.05B | 43.85%5.04B | 43.03%2.62B | -4.15%3.5B | 34.64%1.83B | 27.75%3.65B | 46.56%1.36B | -0.55%2.86B |
| Cost of sales | -50.08%-2.6B | -39.94%-4.22B | -15.48%-1.73B | -26.65%-3.02B | -18.25%-1.5B | -10.50%-2.38B | -72.70%-1.27B | -46.59%-2.16B | -27.71%-735.63M | -12.50%-1.47B |
| Operating expenses | -50.08%-2.6B | -39.94%-4.22B | -15.48%-1.73B | -26.65%-3.02B | -18.25%-1.5B | -10.50%-2.38B | -72.70%-1.27B | -46.59%-2.16B | -27.71%-735.63M | -12.50%-1.47B |
| Gross profit | 9.71%1.44B | 22.86%2.48B | 18.21%1.32B | 80.58%2.02B | 99.41%1.11B | -25.29%1.12B | -10.32%558.27M | 7.77%1.5B | 77.53%622.53M | -11.45%1.39B |
| Selling expenses | -1.06%-332.15M | -11.17%-789.31M | 12.94%-328.66M | -103.84%-710M | -187.79%-377.5M | 38.30%-348.32M | 34.43%-131.17M | -28.70%-564.57M | -189.38%-200.05M | 56.85%-438.67M |
| Administrative expenses | -11.78%-669.41M | -26.54%-1.24B | -53.33%-598.88M | -32.62%-977.87M | 8.37%-390.6M | 20.33%-737.33M | 21.73%-426.29M | -6.37%-925.47M | -31.16%-544.6M | 16.68%-870.01M |
| Impairment and provision | -120.11%-29.5M | 313.30%112.27M | 719.29%146.68M | -94,091.07%-52.64M | -107.04%-23.69M | 100.03%56K | 87.18%-11.44M | -22.46%-176.15M | -11.46%-89.26M | 62.32%-143.84M |
| -Other impairment is provision | -120.11%-29.5M | 313.30%112.27M | 719.29%146.68M | -94,091.07%-52.64M | -107.04%-23.69M | 100.03%56K | 87.18%-11.44M | -22.46%-176.15M | -11.46%-89.26M | 62.32%-143.84M |
| Special items of operating profit | 1,590.84%113.39M | 156.68%85.07M | -109.37%-7.61M | 114.13%33.14M | 264.27%81.21M | -152.09%-234.54M | -136.64%-49.44M | 1,161.82%450.27M | 670.17%134.94M | 59.79%-42.41M |
| Operating profit | -0.27%526.01M | 109.49%648.74M | 30.99%527.45M | 252.45%309.68M | 770.38%402.67M | -172.75%-203.14M | 21.42%-60.07M | 359.67%279.22M | 61.05%-76.44M | 89.04%-107.53M |
| Financing income | -5.57%119.73M | 31.05%239.31M | 64.80%126.79M | 55.94%182.61M | 43.90%76.94M | 27.31%117.11M | 25.70%53.46M | -10.07%91.99M | -15.25%42.53M | -44.56%102.29M |
| Financing cost | 84.32%-7.2M | -5,782.20%-45.94M | -1,709.26%-45.9M | 23.58%-781K | 40.40%-2.54M | 91.95%-1.02M | 42.97%-4.26M | 32.24%-12.7M | 26.79%-7.47M | 64.39%-18.75M |
| Special items of earning before tax | 96.12%-6.73M | -186.72%-548.12M | -14.75%-173.32M | -14.43%-191.17M | -6,449.57%-151.03M | 27.24%-167.06M | 91.21%-2.31M | -144.24%-229.6M | -89.24%-26.24M | 67.27%-94.01M |
| Earning before tax | 45.24%631.81M | -2.12%293.99M | 33.43%435.02M | 218.19%300.35M | 2,576.54%326.04M | -297.14%-254.12M | 80.53%-13.17M | 209.25%128.9M | 60.26%-67.6M | 89.62%-117.99M |
| Tax | -86.09%-115.98M | 57.65%92.4M | -142.30%-62.32M | 14,022.89%58.61M | 2,236.17%147.35M | -98.37%415K | -404.68%-6.9M | 3,068.70%25.41M | 541.36%2.26M | 102.75%802K |
| After-tax profit from continuing operations | 38.40%515.83M | 7.64%386.39M | -21.27%372.7M | 241.49%358.96M | 2,459.52%473.39M | -264.40%-253.7M | 69.29%-20.06M | 231.68%154.32M | 61.51%-65.34M | 89.95%-117.19M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | -143.92%-61.49M | ---- | ---25.21M | ---- | ---- | ---- | ---- |
| Earning after tax | 38.40%515.83M | 29.89%386.39M | -21.27%372.7M | 206.66%297.47M | 2,459.52%473.39M | -280.74%-278.91M | 69.29%-20.06M | 231.68%154.32M | 61.51%-65.34M | 89.95%-117.19M |
| Minority profit | -110.25%-3.7M | 79.95%22.82M | 275.97%36.1M | 3.71%12.68M | 325.62%9.6M | 178.68%12.23M | 118.64%2.26M | 25.56%-15.54M | -57.94%-12.1M | -36.91%-20.87M |
| Shareholders should account for profits from continuing business | ---- | 8.67%363.58M | ---- | 222.32%334.58M | ---- | ---273.52M | ---- | ---- | ---- | ---- |
| Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | -182.74%-49.79M | ---- | ---17.61M | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 54.35%519.53M | 27.66%363.58M | -27.42%336.6M | 197.82%284.79M | 2,178.00%463.79M | -271.40%-291.13M | 58.08%-22.32M | 276.36%169.85M | 67.15%-53.24M | 91.63%-96.31M |
| Basic earnings per share | 53.51%0.0175 | 19.42%0.0123 | -34.48%0.0114 | 194.50%0.0103 | 2,275.00%0.0174 | -270.31%-0.0109 | 60.00%-0.0008 | 77.78%0.0064 | 67.21%-0.002 | 108.28%0.0036 |
| Diluted earnings per share | 51.75%0.0173 | 19.42%0.0123 | -34.10%0.0114 | 194.50%0.0103 | 2,262.50%0.0173 | -270.31%-0.0109 | 60.00%-0.0008 | 77.78%0.0064 | 67.21%-0.002 | 108.28%0.0036 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.